Variant report
Variant | esv3491901 |
---|---|
Chromosome Location | chr6:162066212-162068510 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6916828 | chr6:162066216-162066217 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs6939123 | chr6:162066229-162066230 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs527538118 | chr6:162066237-162066238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9647609 | chr6:162066238-162066239 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs78726523 | chr6:162066252-162066253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75615974 | chr6:162066253-162066254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555823906 | chr6:162066270-162066271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201206787 | chr6:162066276-162066277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73021469 | chr6:162066299-162066300 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs144837149 | chr6:162066326-162066327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555303556 | chr6:162066334-162066335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113137575 | chr6:162066383-162066384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183072433 | chr6:162066387-162066388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558432840 | chr6:162066409-162066410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9647610 | chr6:162066421-162066422 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs539325857 | chr6:162066426-162066427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543964930 | chr6:162066435-162066436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563656835 | chr6:162066451-162066452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529351864 | chr6:162066542-162066543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542662975 | chr6:162066547-162066548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559651123 | chr6:162066550-162066551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6939825 | chr6:162066568-162066569 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs547278976 | chr6:162066583-162066584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566647764 | chr6:162066605-162066606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6901369 | chr6:162066620-162066621 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs532939177 | chr6:162066661-162066662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549536559 | chr6:162066662-162066663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569661140 | chr6:162066688-162066689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138758351 | chr6:162066705-162066706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555117210 | chr6:162066709-162066710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141575399 | chr6:162066754-162066755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73595361 | chr6:162066770-162066771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558469924 | chr6:162066778-162066779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188412367 | chr6:162066781-162066782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139229146 | chr6:162066782-162066783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557486962 | chr6:162066799-162066800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116272820 | chr6:162066844-162066845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs193042039 | chr6:162066890-162066891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185629229 | chr6:162066898-162066899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572885578 | chr6:162066899-162066900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375668664 | chr6:162066919-162066920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540954769 | chr6:162066940-162066941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12209808 | chr6:162066946-162066947 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs139060514 | chr6:162066964-162066965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112155211 | chr6:162066969-162066970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549712994 | chr6:162066972-162066973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563496452 | chr6:162066977-162066978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs529021369 | chr6:162066978-162066979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12203822 | chr6:162066980-162066981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12205219 | chr6:162066986-162066987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Parkinson disease | 0 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:162057600-162068800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr6:162064600-162068400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr6:162067400-162067600 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:162067600-162067800 | Flanking Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr6:162067600-162067800 | Enhancers | Esophagus | oesophagus |
6 | chr6:162068400-162069400 | Enhancers | Cortex derived primary cultured neurospheres | brain |